CC-42344

N/A

Report date: 2024/03/20 15:14:12
NME

Base Information

Drug NameCC-42344
Drug Alias NameCC-42344
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase basic protein 2 inhibitors
TargetsPolymerase basic protein 2
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesCocrystal Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCocrystal Pharma IncCocrystal Pharma Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A